NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Stock Could Be 28% Undervalued As Guidance Rises
Eli Lilly stock has climbed very sharply over the past five years, yet the current valuation checks send a more measured signal, with the Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market based multiples sit closer to fair value. That mix leaves investors weighing a strong price run against an intrinsic value estimate that suggests the shares may still trade below what the underlying cash flows imply.
Eli Lilly has returned about 3.7x over the past 5 years, which...